A5 Laboratories acquires CRO assets and interferon technology from Vida Pharma - MarketLine Financial Deals

A5 Laboratories acquires CRO assets and interferon technology from Vida Pharma

A5 Laboratories acquires CRO assets and interferon technology from Vida Pharma - MarketLine Financial Deals
A5 Laboratories acquires CRO assets and interferon technology from Vida Pharma
Published Jul 12, 2010
2 pages — Published Jul 12, 2010
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

A5 Laboratories has acquired contract research (CRO) assets and a novel interferon production technology from VIDA Pharma Pharmaceutical Manufacturing, Inc., a Canada-based contract manufacturer of nutritional supplements, vitamins, minerals, herbal products, specialty products and diet aides.

  
Source:
Document ID
MA24688_100511
Country
Ticker
AFLB=CA
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "A5 Laboratories acquires CRO assets and interferon technology from Vida Pharma" Jul 12, 2010. Alacra Store. Dec 09, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/A5-Laboratories-acquires-CRO-assets-and-interferon-technology-from-Vida-Pharma-2052-32630>
  
APA:
MarketLine Financial Deals. (2010). A5 Laboratories acquires CRO assets and interferon technology from Vida Pharma Jul 12, 2010. New York, NY: Alacra Store. Retrieved Dec 09, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/A5-Laboratories-acquires-CRO-assets-and-interferon-technology-from-Vida-Pharma-2052-32630>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.